Human Genome Epidemiology Literature Finder
Records 1 - 25 (of 25 Records) |
Query Trace: CBR3[original query] |
---|
Genotype of human carbonyl reductase CBR3 correlates with doxorubicin disposition and toxicity. Pharmacogenetics and genomics 2008 Jul 18 (7): 623-31. Fan L, Goh BC, Wong CI, Sukri N, Lim SE, Tan SH, Guo JY, Lim R, Yap HL, Khoo YM, Iau P, Lee HS, Lee SC |
Genetic polymorphisms in the carbonyl reductase 3 gene CBR3 and the NAD(P)H:quinone oxidoreductase 1 gene NQO1 in patients who developed anthracycline-related congestive heart failure after childhood cancer. Cancer 2008 Jun 112 (12): 2789-95. Blanco Javier G, Leisenring Wendy M, Gonzalez-Covarrubias Vanessa M, Kawashima Toana I, Davies Stella M, Relling Mary V, Robison Leslie L, Sklar Charles A, Stovall Marilyn, Bhatia Smi |
CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients. Cancer science 2008 Oct 99 (10): 2045-54. Lal Suman, Sandanaraj Edwin, Wong Zee Wan, Ang Peter C S, Wong Nan Soon, Lee Edmund J D, Chowbay Balr |
Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial. Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Aug 15 (16): 5258-66. Choi Ji-Yeob, Barlow William E, Albain Kathy S, Hong Chi-Chen, Blanco Javier G, Livingston Robert B, Davis Warren, Rae James M, Yeh I-Tien, Hutchins Laura F, Ravdin Peter M, Martino Silvana, Lyss Alan P, Osborne C Kent, Abeloff Martin D, Hayes Daniel F, Ambrosone Christine |
Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Nov . Blanco JG, Sun CL, Landier W, Chen L, Esparza-Duran D, Leisenring W, Mays A, Friedman DL, Ginsberg JP, Hudson MM, Neglia JP, Oeffinger KC, Ritchey AK, Villaluna D, Relling MV, Bhatia S |
Genetic variation in the carbonyl reductase 3 gene confers risk of type 2 diabetes and insulin resistance: a potential regulator of adipogenesis. Journal of molecular medicine (Berlin, Germany) 2012 Jul 90 (7): 847-58. Chang Yi-Cheng, Liu Pi-Hua, Tsai Yun-Chih, Chiu Yen-Feng, Shih Shyang-Rong, Ho Low-Tone, Lee Wen-Jane, Lu Chieh-Hua, Quertermous Thomas, Curb J David, Lee Wei-Jei, Lee Po-Chu, He You-Han, Yeh Jih-I, Hwang Juey-Jen, Tsai Shu-Huei, Chuang Lee-Mi |
Correlation of aldo-ketoreductase (AKR) 1C3 genetic variant with doxorubicin pharmacodynamics in Asian breast cancer patients. British journal of clinical pharmacology 2013 Jun 75 (6): 1497-505. Voon Pei Jye, Yap Hui Ling, Ma Cho-Yee-Thu, Lu Fan, Wong Andrea L A, Sapari Nur Sabrina, Soong Richie, Soh Thomas I P, Goh Boon-Cher, Lee How-Sung, Lee Soo-Ch |
The relationship between changes in functional cardiac parameters following anthracycline therapy and carbonyl reductase 3 and glutathione S transferase Pi polymorphisms. Journal of chemotherapy (Florence, Italy) 2012 24 (5): 5. Volkan-Salanci B, Aksoy H, Kiratli PO, Tülümen E, Güler N, Oksüzoglu B, Tokgözo?lu L, Erba? B, Alika?ifo?lu M |
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics. Leukemia & lymphoma 2015 Feb 56 (2): 353-60. Melchardt Thomas, Weiss Lukas, Hufnagl Clemens, Neureiter Daniel, Kemmerling Ralf, Morre Patrick, Boekstegers Ann, Hopfinger Georg, Auberger Jutta, Steinkirchner Susanne, Pleyer Lisa, Greil Richard, Egle Alexand |
Risk factors for anthracycline-associated cardiotoxicity. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2015 Nov . Reinbolt Raquel E, Patel Roshan, Pan Xueliang, Timmers Cynthia Dawn, Pilarski Robert, Shapiro Charles L, Lustberg Maryam |
Population pharmacokinetics of Daunorubicin in adult patients with acute myeloid leukemia. Cancer chemotherapy and pharmacology 2016 Oct . Varatharajan Savitha, Panetta John C, Abraham Ajay, Karathedath Sreeja, Mohanan Ezhilpavai, Lakshmi Kavitha M, Arthur Nancy, Srivastava Vivi M, Nemani Sandeep, George Biju, Srivastava Alok, Mathews Vikram, Balasubramanian Poonkuzha |
Evidence for association of SNPs in ABCB1 and CBR3, but not RAC2, NCF4, SLC28A3 or TOP2B, with chronic cardiotoxicity in a cohort of breast cancer patients treated with anthracyclines. Pharmacogenomics 2016 Jan . Hertz Daniel L, Caram Megan V, Kidwell Kelley M, Thibert Jacklyn N, Gersch Christina, Seewald Nicholas J, Smerage Jeffrey, Rubenfire Melvyn, Henry N Lynn, Cooney Kathleen A, Leja Monika, Griggs Jennifer J, Rae James |
Genome-wide association study of cardiotoxicity in the NCCTG N9831 (Alliance) adjuvant trastuzumab trial.
Pharmacogenetics and genomics 2017 Jul . Serie Daniel J, Crook Julia E, Necela Brian M, Dockter Travis J, Wang Xue, Asmann Yan W, Fairweather DeLisa, Bruno Katelyn A, Colon-Otero Gerardo, Perez Edith A, Thompson E Aubrey, Norton Nadi |
NOS3 895G>T and CBR3 730G>A Are Associated with Recurrence Risk in Non-Muscle-Invasive Bladder Cancer with Intravesical Instillations of THP. Chemotherapy 2018 Aug 63 (4): 191-197. Zhou Qidong, Ding Weihong, Weng Yingjie, Ding Guanxiong, Xia Guowei, Xu Jianfeng, Xu Ke, Ding Qia |
Impact of protocol change on individual factors related to course of adverse reactions to chemotherapy for breast cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2019 May . Paula Daniela Polessa, do Brasil Costa Vanessa I, Jorge Rosane V, Nobre Flávio |
Variation in Actionable Pharmacogenetic Markers in Natives and Mestizos From Mexico. Frontiers in pharmacology 2019 10 10 1169. Gonzalez-Covarrubias Vanessa, Morales-Franco Marlet, Cruz-Correa Omar F, Martínez-Hernández Angélica, García-Ortíz Humberto, Barajas-Olmos Francisco, Genis-Mendoza Alma Delia, Martínez-Magaña José Jaime, Nicolini Humberto, Orozco Lorena, Soberón Xavi |
Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) Trial. European journal of drug metabolism and pharmacokinetics 2020 Jan . Hellmann Farina, Völler Swantje, Krischke Miriam, Jamieson David, André Nicolas, Bisogno Gianni, Boddy Alan, Hempel Geo |
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia. Pharmacogenetics and genomics 2021 Jul 31 (5): 108-115. Gándara-Mireles Jesús Alonso, Lares-Asseff Ismael, Reyes Espinoza Elio Aarón, Blanco Javier G, González Font Antonio Emilio, Córdova Hurtado Lourdes Patricia, Castañeda Verónica Loera, Fierro Ignacio Villanueva, Romero Leslie Patrón, Reyes Horacio Alman |
CBR3 V244M is associated with LVEF reduction in breast cancer patients treated with doxorubicin. Cardio-oncology (London, England) 2021 May 7 (1): 17. Lang Jennifer K, Karthikeyan Badri, Quiñones-Lombraña Adolfo, Blair Rachael Hageman, Early Amy P, Levine Ellis G, Sharma Umesh C, Blanco Javier G, O'Connor Trac |
Influence of polymorphisms in anthracyclines metabolism genes in the standard induction chemotherapy of acute myeloid leukemia. Pharmacogenetics and genomics 2021 Mar . Megías-Vericat Juan Eduardo, Martínez-Cuadrón David, Herrero María José, Rodríguez-Veiga Rebeca, Solana-Altabella Antonio, Boluda Blanca, Ballesta-López Octavio, Cano Isabel, Acuña-Cruz Evelyn, Cervera José, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador F, Montesinos P |
Genotype Analysis of ABCC1, NCF4 and CBR3 Polymorphism and the Association With Childhood Acute Lymphoblastic Leukemia in Mexican Childhood Population. Frontiers in pharmacology 2021 2 11 616630. Gándara-Mireles Jesús Alonso, Lares-Asseff Ismael, Reyes Espinoza Elio Aarón, Blanco Javier G, Chairez Hernández Isaias, Córdova Hurtado Lourdes Patricia, Loera Castañeda Verónica, Patrón Romero Leslie, Venzor Sánchez Cristina, Payan Gándara Hugo, Arechiga Gurrola Dinora, Almanza Reyes Horac |
Impact of single-nucleotide variants and nutritional status on population pharmacokinetics of Doxorubicin, and its effect on cardiotoxicity in children with leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2022 Sep 10781552221117810. Gándara-Mireles Jesús Alonso, Lares-Asseff Ismael, Reyes Espinoza Elio Aarón, Fierro Ignacio Villanueva, Castañeda Verónica Loera, Cordova Hurtado Lourdes Patricia, González Carla Díaz, Romero Leslie Patrón, Reyes Horacio Alman |
Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of personalized medicine 2022 4 12 (4): . Virgili Manrique Anna C, Salazar Juliana, Arranz María Jesús, Bagué Silvia, Orellana Ruth, López-Pousa Antonio, Cerdà Paula, Gracia Isidre, Majercakova Katarina, Peiró Ana, Trullols Laura, Fernández Manuel, Valverde Sandra, Quintana María Jesús, Bell Olga, Artigas-Baleri Alícia, Sebio A |
Genes of Predisposition to Childhood Beta-Cell Acute Lymphoblastic Leukemia in the Kazakh Population. Asian Pacific journal of cancer prevention : APJCP 2023 8 24 (8): 2653-2666. Gulnara Svyatova, Riza Boranbayeva, Galina Berezina, Lyazat Manzhuova, Alexandra Murtazaliye |
Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial. Frontiers in oncology 2023 6 13 1139347. Pooja P Advani, Kathryn J Ruddy, Joerg Herrmann, Jordan C Ray, Emily C Craver, Greg Yothers, Reena S Cecchini, Corey Lipchik, Huichen Feng, Priya Rastogi, Eleftherios P Mamounas, Sandra M Swain, Charles E Geyer, Norman Wolmark, Soonmyung Paik, Katherine L Pogue-Geile, Gerardo Colon-Otero, Edith A Perez, Nadine Nort |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 29, 2024
- Content source: